Evaluation of cell-laden polyelectrolyte hydrogels incorporating poly(l-Lysine) for applications in cartilage tissue engineering by Lam, Johnny et al.
Evaluation of Cell-Laden Polyelectrolyte Hydrogels 
Incorporating Poly(L-Lysine) for Applications in Cartilage Tissue 
Engineering
Johnny Lam1, Elisa C. Clark1, Eliza L.S. Fong1, Esther J. Lee1, Steven Lu1, Yasuhiko 
Tabata2, and Antonios G. Mikos1,*
1Department of Bioengineering, Rice University, Houston, TX
2Department of Biomaterials, Institute of Frontier Medical Sciences, Kyoto University, Kyoto, 
Japan
Abstract
To address the lack of reliable long-term solutions for cartilage injuries, strategies in tissue 
engineering are beginning to leverage developmental processes to spur tissue regeneration. This 
study focuses on the use of poly(L-lysine) (PLL), previously shown to up-regulate mesenchymal 
condensation during developmental skeletogenesis in vitro, as an early chondrogenic stimulant of 
mesenchymal stem cells (MSCs). We characterized the effect of PLL incorporation on the 
swelling and degradation of oligo(poly(ethylene) glycol) fumarate) (OPF)-based hydrogels as 
functions of PLL molecular weight and dosage. Furthermore, we investigated the effect of PLL 
incorporation on the chondrogenic gene expression of hydrogel-encapsulated MSCs. The 
incorporation of PLL resulted in early enhancements of type II collagen and aggrecan gene 
expression and type II/type I collagen expression ratios when compared to blank controls. The 
presentation of PLL to MSCs encapsulated in OPF hydrogels also enhanced N-cadherin gene 
expression under certain culture conditions, suggesting that PLL may induce the expression of 
condensation markers in synthetic hydrogel systems. In summary, PLL can function as an 
inductive factor that primes the cellular microenvironment for early chondrogenic gene expression 
but may require additional biochemical factors for the generation of fully functional chondrocytes.
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1. Introduction
Articular cartilage is the specialized connective tissue that enables frictionless bone 
articulation within synovial joints in the body. Its elegantly organized extracellular matrix 
comprises specialized collagens and proteoglycans that together contribute to the favorable 
viscoelastic and swelling properties of the tissue. Unlike bone, articular cartilage is devoid 
of any vascularity, lymphatics, and nerves [1]. Due to this avascularity and the low mitotic 
activity of its resident chondrocytes, articular cartilage inherently exhibits a limited 
endogenous capacity for regeneration. In the absence of long-lasting clinical solutions, such 
cartilage-related injuries continue to impose a significant economic burden on society [2] 
and remain a leading cause of global disability [3, 4]. To address these shortcomings in the 
management of cartilage defects, current efforts are focused on the use of tissue engineering 
principles to develop better solutions.
By definition, hydrogels are three-dimensional (3D) polymer networks that consist of 
various hydrophilic components crosslinked to form water-insoluble matrices and have been 
investigated for applications in cartilage repair due to their highly favorable material 
properties [5]. These water-absorbent constructs can be fabricated from a wide variety of 
synthetic [6–9] or natural [10–16] materials for the encapsulation of mesenchymal stem cells 
(MSCs) and to provide in vivo-like conditions reminiscent of native articular cartilage 
microenvironments. While strategies aimed at maximizing their reparative capacity through 
the optimization of in vitro chondrogenic induction protocols have proven relatively 
successful [17–20], the ability to induce complete healing of damaged cartilage reliably [21] 
has not yet been achieved.
Recent strategies in cartilage tissue engineering are beginning to mimic specific stages in 
skeletogenesis with the goal of generating functional articular cartilage tissues [22–24]. Pre-
cartilaginous condensation, a developmental process characterized by dense cellular 
aggregation and significantly increased cell-cell contacts, is believed to be critical in the 
governance of natural cartilage formation in embryo [25]. During condensation, the rapid 
onset of cell-cell interactions is largely mediated by a small number of key cell adhesion 
molecules, of which N-cadherin plays a special role [26–29]. Interestingly, previous 
research has demonstrated that the cationic polypeptide poly(L-Lysine) (PLL) possesses 
chondrostimulatory properties and can stimulate the chondrogenesis of mesenchymal 
micromass cells in developing chick limbs [30, 31]. Several mechanisms for the 
physiological effects of PLL on chondrogenic differentiation have been proposed, including 
alteration of glycosaminoglycan biosynthesis and distribution, crosslinking of proteoglycans 
and cells, changing of cell morphology, and interaction with other biochemical cues [27]. 
Despite these promising reports, the use of PLL to induce embryonic signaling processes 
during chondrogenesis in cartilage tissue engineering remains heavily unexplored, especially 
within the context of 3D culture systems.
In this study, we hypothesized that the physical incorporation of PLL within hydrogels can 
stimulate the chondrogenic gene expression of encapsulated MSCs. To test this hypothesis, 
we utilized oligo(poly(ethylene glycol) fumarate) (OPF), a PEG-based macromer that can be 
crosslinked to yield hydrolytically degradable hydrogels of highly tunable mechanical and 
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swelling properties [32, 33], as a synthetic platform to isolate the effects of PLL. 
Considering the cationic nature of PLL and the presence of negative charges from the OPF 
macromers comprising the hydrogel backbone, it is anticipated that both moieties will form 
strong electrostatic interactions, leading to the bulk retention of PLL. Further, it is expected 
that the incorporation of PLL will affect the swelling and degradation of these hydrogel 
constructs. In order to evaluate these hypotheses, a number of specific objectives were 
established as follows: (i) to determine the amount of PLL retained or released from OPF 
hydrogels when incorporated at various concentrations; (ii) to characterize the swelling and 
degradation of PLL-laden OPF hydrogels as functions of PLL molecular weight (MW) and 
PLL loading amount; (iii) to assess the effects of PLL incorporation on encapsulated MSC 
chondrogenic gene expression as functions of PLL MW and PLL dosage; and (iv) to 
evaluate potential additive or synergistic effects between PLL presentation and OPF MW on 
MSC chondrogenic gene expression and condensation.
2. Materials and Methods
2.1 Experimental Design
The specific objectives of this overall investigation were completed via a series of individual 
studies, which were designed as follows. In order to determine the amount of PLL retained 
or released from OPF hydrogels, two experiments were designed as outlined in Table 1. For 
a third experiment, fluorescein isothiocyanate (FITC) conjugated PLL (PLL-FITC, 50 kDa) 
was loaded into OPF hydrogels at increasing concentrations (500 ng/construct, 5 µg/
construct, or 20 µg/construct) according to Table 2.
A full factorial study was designed to characterize the effects of PLL MW and PLL loading 
on the swelling and degradation of synthetic OPF hydrogels. Specifically, the factors of (A) 
PLL MW, (B) PLL loading per construct, and (C) OPF MW were investigated as outlined in 
Table 3 in order to identify main and combinatory effects on OPF swelling and degradation. 
The PLL MWs of 50 and 225 kDa were determined based on previously reported values 
used in the chondrogenic stimulation of chick limb mesenchymal cells in micromass culture 
in vitro [30]. The PLL loading concentrations were chosen to yield a sufficiently wide range 
in order to elucidate the effects of PLL on bulk hydrogel swelling, where the low 
concentration levels reflect those used for the chondrogenic stimulation of cells in 
monolayer [34].
The effects of PLL presentation on cells encapsulated in such composite hydrogels were also 
investigated. As shown in Table 4, the effects of PLL MW and PLL dosage on MSCs 
encapsulated in OPF hydrogel composites were first investigated using a factorial design, 
where the MW factor comprised two levels (50 or 225 kDa) and the dosage factor consisted 
of three levels (250 or 500 ng/construct). Cell-laden hydrogels without any PLL 
incorporation were used as negative controls. The PLL MW (225 kDa) and amount (500 ng/
construct) yielding the highest chondrogenic gene expression in encapsulated MSCs were 
chosen in the follow-up experiment, which investigated any potential additive or synergistic 
effects of PLL presentation in combination with OPF MW on MSC chondrogenic gene 
expression as shown in Table 5. These OPF MWs were chosen based on a previous study 
from our laboratory, which demonstrated that an increase in swelling ratio (due to an 
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increase in nominal OPF MW from 10K to 35K) resulted in enhanced type II collagen gene 
expression [35].
2.2 OPF Synthesis and Characterization
OPF was synthesized using poly(ethylene glycol) (PEG) of nominal MWs of either 10,000 
g/mol or 35,000 g/mol, according to previously described methods [32]. In brief, PEG was 
first dried via azeotropic distillation in toluene and dissolved in anhydrous dichloromethane. 
Triethylamine and fumaryl chloride were then added drop-wise to initiate the synthesis 
reaction, which was allowed to proceed for 2 days. The resultant product was purified by 
removing dichloromethane using rotoevaporation, separating salt precipitates with ethyl 
acetate, washing with ethyl ether, and subsequent drying. The synthesized polymers were 
characterized via gel permeation chromatography and sterilized prior to use by exposure to 
ethylene oxide gas for 12 h following established protocols [36].
2.3 Fabrication of PLL-laden Hydrogels
Acellular OPF hydrogels were fabricated following previously established procedures [37]. 
Briefly, a base formula of 100 mg OPF and 50 mg PEG diacrylate (PEG-DA, Mn 3,400 g/
mol; Laysan, Arab, AL) dissolved in 410 µL of PBS was used to prepare the hydrogel 
precursor solution. For PLLladen hydrogels, PLL (Sigma Aldrich) of two different average 
MWs (either 50 kDa or 225 kDa) was dissolved in the polymer precursor solution at various 
concentrations prior to crosslinking in order to achieve the desired incorporation amounts 
per construct (250 or 500 ng/construct). For the OPF-Post samples of the PLL retention 
study, a PLL solution was used to rehydrate crosslinked hydrogels that were dried 
immediately following the removal of sol fraction in PBS for 2 h in order to achieve the 
desired loading concentration. The two different average MWs of PLL were chosen in 
accordance to previous studies demonstrating the effect of PLL size on cartilage nodule 
formation in micromass cultures of chick mesenchyme limb bud cells, where larger PLL 
size generally increased tissue formation [30]. These concentrations were chosen to reflect 
similar PLL concentrations that have been previously used for the chondrogenic stimulation 
of mesenchymal derived cells in monolayer [30, 34]. Equal parts (46.8 µL) of the thermal 
radical initiators, 0.3 M of ammonium persulfate (APS, Sigma Aldrich) and 0.3 M of 
N,N,N’,N’ – tetramethylethylenediamine (TEMED, Sigma Aldrich) were then added to the 
precursor solution to initiate the crosslinking reaction. After gentle mixing, the precursor 
solution was quickly injected into cylindrical Teflon molds (3 mm diameter and 1 mm 
thickness) and allowed to crosslink for 8 min at 37°C. The resultant hydrogels were 
transferred to PBS (pH 7.4), incubated at room temperature or 37°C for 28 days, and 
collected at various time points over 28 days for characterization.
2.4 Swelling and Degradation of OPF-PLL Hydrogels
Fabricated hydrogels for the swelling and degradation study (n=4) were placed in 2 mL of 
PBS (pH 7.4) in a 24 well plate and incubated at 37°C and under agitation (shaker table at 
90–100 RPM) for 28 days. At days 1, 7, 14, and 28, the swelling ratio and mass loss of the 
hydrogels were determined using the following equations: swelling ratio = (Ws – Wd)/Wd 
and % mass loss = (Wi – Wd)/Wi × 100 (%), where Wi, Ws, and Wd represent the weight of 
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dried hydrogel immediately following fabrication before swelling, the weight of wet 
hydrogel after swelling at each time point, and the weight of dried hydrogel after swelling at 
each time point, respectively.
2.5 Measurement of PLL Retention in OPF-PLL Hydrogels
Briefly, blank OPF hydrogels, OPF hydrogels with PLL loaded prior to hydrogel 
crosslinking (OPF-Pre), and OPF hydrogels with PLL loaded after hydrogel fabrication 
(OPF-Post) were incubated after the removal of sol fraction in either phosphate buffered 
saline (PBS, pH 7.4) or a KCl/NaOH basic buffer (pH 13) for 24 h at 37°C. At 2 h and 24 h, 
the supernatant is collected from each sample (n=3) and subjected to biochemical analysis. 
In order to characterize PLL retention within OPF hydrogels over longer periods of time in 
vitro, blank OPF and OPF-Pre samples were incubated in PBS over 28 days at 37°C. At 2 h, 
24 h, 7 days, 14 days, and 21 days, samples (n=3) were switched to basic buffer and 
incubated for 24 h before collection, where the resultant supernatant was then analyzed for 
PLL.
The amount of PLL retained was biochemically analyzed using the ortho-pthalaldehyde 
(OPA) assay according to previously established procedures [38, 39]. The OPA working 
reagent was freshly prepared at each time point following a base formula by mixing 1 mL of 
OPA (Sigma Aldrich) dissolved in ethanol (40 mg/mL), 25 mL borate buffer (0.4 M borate, 
pH 9.5), 12.5 mL 20 w/w% sodium dodecyl sulfate (Sigma Aldrich) in deionized water, 0.1 
mL 2-mercaptoethanol, and enough water to fill up to 50 mL in a beaker. The supernatants 
were combined with the OPA working reagent within individual wells of an opaque 96-well 
plate at a 1:1 reagent-to-analyte solution ratio and incubated at room temperature for 5 min. 
The fluorescence was measured using a plate reader (FL x800 Fluorescence Microplate 
Reader; BioTek Instruments, Winooski, VT) with excitation and emission wavelengths of 
360 nm and 455 nm, respectively. PLL of the same MW was used to generate a standard 
curve.
PLL-FITC laden constructs (n=3) were incubated in PBS over 28 days at room temperature. 
The supernatant was collected at .08 (2 h), 1, 4, 7, 11, 14, 18, 21, 25, and 28 days and 
analyzed using a spectrofluorometric plate reader with respective excitation and emission 
wavelengths of 485 nm and 528 nm to determine the release of PLL.
2.6 Gelatin Microparticle Fabrication
Gelatin microparticles (GMPs) were fabricated using acidic gelatin with an isoelectric point 
of 5.0 (Nitta Gelatin Inc., Osaka, Japan) according to previously established protocols [40]. 
Briefly, a 10% w/v aqueous solution of gelatin was first prepared by dissolving 5 g of 
gelatin in 45 mL of distilled, deionized water (ddH2O) at 60°C, added dropwise to 250 mL 
of olive oil (Sigma Aldrich) containing 0.5 wt.% Span 80 under mixing at 500 RPM, and 
chilled in an ice/water bath for 30 min with continued mixing. 100 mL of chilled acetone 
was then added to the emulsion, which was allowed to stir for an additional 30 min. After 
this step, the formed GMPs were collected by filtration and washed with acetone. The 
collected GMPs were crosslinked in an aqueous solution containing 10 mM glutaraldehyde 
for 20 h at 15°C, where glycine was added to a concentration of 25 mM afterward in order to 
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quench any unreacted glutaraldehyde. Following crosslinking, the GMPs were vacuum-
filtered, washed with ddH2O, and freeze-dried overnight. Dried GMPs of 50–100 µm in 
diameter were selected by sieving and sterilized via exposure to ethylene oxide gas for 12 h 
before use. Prior to encapsulation into hydrogels, sterilized GMPs were first swollen with 
PBS (55 µL of PBS per 11 mg of dried GMPs) to achieve swelling according to previously 
established methods [40]. It was previously shown that GMPs encapsulated within OPF 
hydrogel composites improved chondrocyte proliferation [41] and enabled cell aggregation 
when compared to blank hydrogel controls, indicating improved cell-material interactions 
[36]. As such, GMPs were incorporated into hydrogels in order to provide moieties for cell-
material interactions and to facilitate hydrogel degradation [42, 43].
2.7 Rabbit Marrow-derived MSC Isolation and Culture
All of the experimental protocols including the use of cells for this study were reviewed and 
approved by the Rice University Institutional Animal Care and Use Committee, and 
conducted in accordance with the National Institutes of Health animal care and use 
guidelines. Rabbit marrow-derived MSCs were harvested from the tibiae of six skeletally 
mature 6-month-old male New Zealand White rabbits following previously described 
protocols [19]. The bone marrow was plated for the isolation of adherent cells and cultured 
in general medium (GM) containing low glucose Dulbecco’s modified Eagle’s medium 
(LG-DMEM), 10% v/v fetal bovine serum (FBS), and 1% v/v penicillin/streptomycin/
fungizone (PSF) for 2 weeks. Non-adherent cells were removed during routine media 
changes. The rabbit marrow-derived MSCs were then pooled together (from six total 
rabbits) to minimize interanimal variation and then cryopreserved until use as previously 
described [19, 42, 43]. For MSC expansion and hydrogel encapsulation in studies involving 
cell-laden constructs, cryopreserved cells were thawed at 37 °C and cultured at a density of 
3,500 cells per cm2 in T-225 tissue culture flasks in GM up to passage three, at which point 
a cell suspension is prepared for hydrogel encapsulation.
2.8 Fabrication of Cell-laden Hydrogel Composites
The procedures for the fabrication of acellular OPF hydrogels were generally followed for 
the fabrication of cell-laden hydrogel composites with a few exceptions. Specifically, 100 
mg OPF and 50 mg PEG-DA were both dissolved in 300 µL of PBS and combined with 110 
µL of swollen GMPs to generate the polymer precursor solution. Equal parts of thermal 
radical initiator solutions APS and TEMED were then added as previously described. After 
mixing of the precursor solution to initiate the crosslinking reaction for 2–3 min, a cell 
suspension (6.7 million cells in 168 µL of PBS) of MSCs is then added in order to obtain a 
final concentration of 10 million cells per mL and gently mixed. The solution was then 
quickly injected into cylindrical Teflon molds (6.0 mm diameter and 1.0 mm thickness) and 
incubated at 37°C for 8 min to complete crosslinking.
After fabrication, cell-laden hydrogel constructs were transferred to individual wells of a 24-
well plate and cultured in 2 mL of serum-free chondrogenic medium (CM) containing LG-
DMEM, ITS+ Premix (6.25 µg/mL insulin, 6.25 µg/mL transferrin, 6.25 µg/mL selenious 
acid, 5.35 µg/mL linoleic acid, and 1.25 µg/mL bovine serum albumin) (Corning, Corning 
NY), 50 mg/L ascorbic acid, 10−7 M dexamethasone, and 1% v/v PSF for up to 28 days. No 
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chondrogenic growth factors were included in the medium in order to isolate the effects of 
PLL alone on chondrogenic gene expression. For the experiment described, the CM was 
supplemented with β-glycerophosphate (β-GP) in order in investigate the chondrogenic as 
well as mineralization potential of encapsulated MSCs. The medium was changed every 3 
days. At each prescribed time point (0, 7, 14, or 28 days), samples were retrieved from tissue 
culture and collected for biochemical assays (n=4) and quantitative real-time polymerase 
chase reaction (n=4).
2.9 Real-Time Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
Cell-laden hydrogel composites were processed for RT-PCR in order to quantify the 
expression of selected genes as indicators of chondrogenic differentiation. Total RNA from 
collected samples were isolated at various time points using the RNeasy Mini Kit (Qiagen, 
Valencia, CA) following established protocols [19]. The isolated RNA from samples were 
reverse-transcribed into cDNA using SuperScript III transcriptase (Invitrogen) and Oligo dT 
primers (Promega), and the final cDNA transcripts were used for RT-PCR (7300 Real-Time 
PCR System, Applied Biosystems, Foster City, CA) to evaluate the gene expression for type 
II collagen (Col II), type I collagen (Col I), aggrecan (Agg), versican (VSN), sex-
determining region Y-box 9 (Sox9), N-cadherin (CDH2), type X collagen (Col X), and 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The gene expression data were 
analyzed using the 2−ΔΔCt method as described [44, 45]. All gene expression data were 
normalized to that of the housing keeping gene, GAPDH, and are expressed as the fold ratio 
as compared to the baseline expression of the control group at day 0. For the experiments 
described in this study, the control group comprised the cell-laden 10K OPF samples 
without any PLL incorporation, which were analyzed immediately following cell 
encapsulation. The primer sequences used are listed in Table 6.
2.10 Biochemical Assays
At each time point, cell-laden hydrogel samples were collected and frozen in −20°C until 
use for biochemical analysis. Samples were thawed, homogenized via needle and syringe, 
and digested in 500 µL of proteinase K solution (1 mg/mL proteinase K, 0.01 mg/mL 
pepstatin A and 0.185 mg/mL iodoacetamide dissolved in 50 mM tris(hydroxymethyl 
aminomethane)/1 mM ethylenediaminetetraacetic acid buffer, pH 7.6 adjusted by HCl) at 
56°C for ~16 h. After the digestion of samples, specimens were then subjected to three 
freeze-thaw cycles followed by probe sonication.
DNA content, which was used as an indicator of construct cellularity, was quantified using 
the Quant-iT PicoGreen dsDNA Assay Kit (Molecular Probes, Eugene, OR) following the 
manufacturer’s instructions. Cell lysates were combined with assay buffer and the 
PicoGreen dye solution within wells of an opaque 96-well assay plate and allowed to 
incubate for 10 min at room temperature. The fluorescence was quantified using excitation 
and emission wavelengths of 485 nm and 528 nm (FL x800 Fluorescence Microplate 
Reader; BioTek Instruments, Winooski, VT), respectively. Lambda DNA provided by the 
manufacturer was used to generate a standard curve.
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Glycosaminoglycan (GAG) content, which was used to indicate extracellular matrix 
deposition and synthetic activity, was measured using the dimethylmethylene blue (DMMB) 
colorimetric assay as previously described [46]. Cell lysates were combined with DMMB 
color reagent within wells of a clear 96-well assay plate and quantified for absorbance at 520 
nm (PowerWave x340 Microplate Reader; BioTek Instruments). GAG concentrations were 
determined relative to a chondroitin sulfate standard curve. To determine the synthetic 
activity of cells within the hydrogel constructs, the resulting total GAG amounts from each 
sample were normalized to the total DNA amount from that sample.
Hydroxyproline (HYP) content, which was used to indicate total collagen amount and 
synthetic activity, was determined using a colorimetric assay following previously 
established protocols [19]. Cell lysates were combined with an equal volume of 4 N NaOH 
and hydrolyzed via autoclave for 15 min at 121°C (~50 min processing time). The resultant 
solutions were neutralized with HCl and acetic acid to pH 6.5–7.0 and divided into duplicate 
reactions. Chloramine-T, followed by p-dimethylaminobenzaldehyde solutions, was 
subsequently added and the absorbance at 570 nm was measured with a plate reader. The 
HYP concentrations were measured relative a standard curve generated using trans-4-
hydroxy-L-proline. To determine the collagen synthetic activity of cells within the hydrogel 
constructs, the resulting total HYP amounts from each sample were divided by the total 
DNA amount from that sample. Due to the presence of GMPs in cell-laden hydrogels, which 
comprise denatured collagen, HYP/DNA values for each group were also normalized to day 
0 HYP/DNA values for that same group in order to evaluate changes in collagen synthetic 
activity.
The calcium content was measured to assess the propensity of stimulated MSCs to undergo 
hypertrophic endochondral ossification. Acetic acid was added to cell lysates to achieve a 
final acidic concentration of 0.5 M for all samples, which were then allowed to incubate at 
room temperature overnight. This releases calcium from the homogenized cell-laden 
hydrogel composites. The calcium content was then quantified using a colorimetric assay. In 
brief, treated samples were combined with calcium arsenazo III reagent (Sekisui 
Diagnostics, Lexington, MA) and the absorbance was measured at 650 nm using a plate 
reader. The calcium concentrations were determined relative to a calcium chloride standard 
curve. Calcium concentrations were then normalized to the day 0 values within each group 
in order to characterize mineralization capacity over time.
2.11 Histology
Cell-laden OPF hydrogel composites were fixed for histology in 10% neutral buffered 
formalin (Fisher Scientific, Pittsburg, PA), soaked in a solution of phosphate-buffered saline 
with 15% sucrose to prevent rapid water crystal formation, and then embedded overnight in 
HistoPrep freezing medium (Fisher Scientific). After freezing, blocks were sectioned into 
10–15 µm thick slices using a cryostat (Leica CM 1850 UW; Leica Biosystems Nussloch 
GmbH, Germany) and mounted onto glass slides. Sections were stained using Alcian Blue 
and Fast Green in order to visualize the extracellular matrix deposition and cell distribution, 
respectively. Bright-field images were obtained using a light microscope equipped with a 
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digital camera attachment for image capture (Axio Imager.Z2 with AxioCam MRc5; Carl 
Zeiss MicroImaging GmbH, Germany).
2.12 Statistical Analysis
All results are presented as means ± standard deviations. Statistical analysis of all data was 
performed using the SAS JMP Pro 11 software package. For the PLL release data, the 
swelling and degradation data, and the biochemical assay data, one-way ANOVA and 
Tukey’s HSD multiple comparison tests were performed to determine significant differences 
between groups. The RT-PCR data were analyzed using the Kruskal-Wallis test following 
by the Mann-Whitney U test to determine significant differences between groups [48, 49]. A 
confidence interval of 95% was utilized and differences were considered significant when 
p<0.05.
3. Results
3.1 Retention and Release of PLL from PLL-laden OPF Hydrogels
We hypothesized that cationic PLL would undergo strong ionic interactions with the 
electronegative carboxyl moieties on the OPF backbone when incorporated into OPF 
hydrogels. However, the addition of PLL during the hydrogel crosslinking process could 
also potentially result in addition reactions between the pendant amines on PLL and the 
unsaturated carbon-carbon double bonds on the fumarate blocks of OPF. To determine the 
mechanism of the interactions between PLL and OPF, the first retention experiment 
compared blank OPF hydrogels (OPF) to OPF hydrogels with PLL loaded during 
crosslinking (OPF-Pre) and to OPF hydrogels with PLL loaded after crosslinking (OPF-
Post), where the OPF-Post hydrogels were generated by swelling dried hydrogels in a PLL-
containing solution. In analyzing the supernatant from each group in PBS (pH 7.4) after 24 h 
using the detection of primary amines as an indirect measure of PLL, we found that PLL 
was detected only in the OPF-Post group (Figure 1a). Notably, when the supernatants were 
analyzed from parallel experimental groups incubated in basic buffer (pH 13) after 24 h, 
PLL was detected for both OPF-Pre and OPF-Post groups. Additionally, significantly more 
PLL was detected in the supernatant of the OPF-Pre group in basic conditions when 
compared to the OPF-Pre supernatants at neutral pH (Figure 1b).
Next, to evaluate the retention of PLL within OPF hydrogels over longer durations, OPF and 
OPF-Pre hydrogels were incubated at neutral pH in PBS over 21 days. Comparing the sol 
fractions after 2 h, higher levels of primary amines were detected in the OPF control group, 
likely due to the presence of amine groups from the thermal radical initiators (APS and 
TEMED) used for chemical crosslinking (Figure 1c). Subsequently, at 7, 14, and 21 days, no 
PLL was detected in the supernatant of the OPF-Pre group. Following the collection of the 
supernatant at each time point, hydrogel samples were transferred to basic buffer and 
incubated for an additional 24 h in order to release any retained PLL into the supernatant. 
Higher levels of primary amines were detected in the supernatant of the OPF-Pre group as 
compared to the OPF group at days 1, 7, and 21, suggesting that PLL was indeed retained 
within the hydrogels and subsequently released in basic conditions (Figure 1d).
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The release of PLL from PLL-laden hydrogels as influenced by the initial PLL loading 
concentration was further characterized using FITC conjugated PLL (PLL-FITC). The 
cumulative release profiles of PLL-FITC from OPF-500ng, OPF-5µg, and OPF-20µg 
hydrogels are shown in Figures 2a and 2b. Each PLL-laden group exhibited an initial burst 
release at 2 h ranging from 1% to 7% of the initial loading amount, where higher amounts of 
PLL-FITC loaded initially resulted in a greater burst release. Following the burst release, the 
amount of PLL-FITC released from all PLL-laden groups stabilized by day 28 to 
approximately 14% of the initial loading amount for the 10K hydrogels and up to 25% for 
the 35K hydrogels. Specifically, the amount of PLL-FITC released translates into an 84.1%, 
86.0%, and 83.9% retention of the loaded PLL-FITC for OPF-500ng, OPF-5µg, and 
OPF-20µg 10K hydrogels, respectively. 75.0%, 81.8%, and 76.5% of the loaded PLL-FITC 
was retained for OPF-500ng, OPF-5µg, and OPF-20µg 35K hydrogels, respectively. To 
visualize the incorporation of PLL-FITC within the hydrogels, hydrogel samples were 
collected at 7 and 28 days and imaged using fluorescence microscopy. Higher fluorescent 
intensities were observed for groups incorporating higher amounts of PLL-FITC (Figure2c 
and 2d). Decreased fluorescence from the incorporated PLL-FITC at later time points were 
likely a result of the degradation of the FITC signal. Indeed, the PLL-FITC stock used to 
generate the standard curve for the analysis of released PLL exhibited decreased fluorescent 
signals over time at ambient temperature.
3.2 Characterization of the Swelling Behavior and Degradation of OPF Hydrogels 
Incorporating PLL of Varying Size and Loading Amount
Given that the PLL was largely retained within OPF hydrogels over the timeframe 
evaluated, the influence of PLL on the swelling behavior and degradation of OPF hydrogels 
was also investigated using the formulations outlined in Table 3. The mean equilibrium 
swelling ratios, as affected by PLL MW, PLL incorporation, and PLL dosage, were first 
compared between 10K OPF hydrogels (Figure 3a). At day 1, both formulations 
incorporating high MW PLL, 10K225Hi and 10K225Lo, and the formulation containing a 
high amount of low MW PLL, 10K50Hi, exhibited greater swelling ratios when compared to 
the control group. At day 7, 10K225Lo hydrogels had higher swelling ratios when compared 
to 10K225Hi hydrogels and blank 10K controls. By day 28, however, the blank 10K control 
hydrogels and 10K50Lo hydrogels maintained the highest equilibrium swelling ratios, where 
the former was greater than the 10K50Hi formulations and the latter was greater when 
compared to both the 10K50Hi and 10K225Lo formulations.
A comparison of the equilibrium swelling ratios between 35K OPF hydrogels (Figure 3b) 
revealed similar differences between groups as those observed for their 10K counterparts. 
Specifically, 35K225Hi, 35K225Lo, and 35K50Hi hydrogels initially exhibited greater 
equilibrium swelling ratios when compared to 35K control hydrogels at day 1; both 35K225 
formulations also maintained higher swelling ratios when compared to 35K50Lo hydrogels 
at this time point. Unlike their 10K hydrogel counterparts, 35K225Hi, 35K225Lo, and 
35K50Lo had lower swelling ratios when compared to 35K50Hi and blank 35K control 
hydrogels as early as day 7. At day 14, 35K225Hi hydrogels retained the lowest swelling 
ratios when compared to 35K50Hi, 35K225Lo, and blank 35K hydrogels. By day 28, blank 
35K hydrogels retained the highest equilibrium swelling ratios when compared to all PLL-
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laden formulations with the exception of 35K225Lo hydrogels, which swelled more than 
those from 35K225Hi and 35K50Lo formulations.
Differences in mass loss manifested between 10K formulations only at the early time points 
of days 1 and 7 (Figure 3c). At day 1, 10K50Lo hydrogels maintained the lowest initial mass 
loss when compared to all other groups except for 10K225Lo hydrogels. At day 7, both 
10K50Lo and 10K225Hi hydrogels had the least mass loss when compared to all other 
groups. The only differences in mass loss observed between 35K hydrogel formulations 
occurred at day 7, where 35K225Hi and blank 35K control hydrogels had more mass loss 
than 35K50Hi hydrogels (Figure 3d). The mean swelling ratio and mass loss data, as well as 
a formal main effects analysis of the data, are presented in Reference [47].
3.3 Effects of PLL Loading, PLL MW, and PLL Dosage on the Chondrogenic Gene 
Expression of Encapsulated MSCs
MSCs were encapsulated in OPF hydrogels using the formulations outlined in Table 4, 
where hydrogels without any PLL incorporated served as the negative control. These cell-
laden hydrogels from the first cell study were cultured in defined chondrogenic media 
supplemented with β-GP in order to investigate their chondrogenic as well as mineralization 
potential. First, assessment of cell viability at 24 h and 7 days following hydrogel 
encapsulation indicated that cells remained viable and that the incorporation of PLL did not 
negatively affect cell viability [47]. We have also previously shown that MSCs encapsulated 
in OPF hydrogel composites remained viable over 28 days of culture in vitro [42].
The influence of PLL MW and dosage on the chondrogenic gene expression of encapsulated 
MSCs was then evaluated at an early (day 7) and late (day 28) time point. With the 
exception of the type II/type I collagen fold ratio, the effects of PLL on chondrogenic gene 
expression were largely observed at day 7. Specifically, the incorporation of 225 kDa PLL 
resulted in increased type II collagen gene expression at both loading dosages when 
compared to the control (Figure 4a). This effect was not observed for 50 kDa PLL. 
Interestingly, the incorporation of 50 kDa PLL at 250 ng per construct led to a decrease in 
type II collagen expression at day 7 when compared to the control group. By day 28, all 
groups exhibited similar type II collagen expression levels, which were expected from 
MSCs encapsulated in synthetic hydrogel systems. In considering the fold ratio of type II to 
type I collagen, only 225 kDa PLL incorporated at 500 ng per construct elicited increases in 
the fold expression ratio, which was reflective of decreases in type I collagen expression, 
that was sustained over 28 days when compared to all other groups (Figure 4b). Notably, 50 
kDa PLL at both loading concentrations (250 and 500 ng per construct) resulted in initial 
decreases in type II/type I collagen fold ratio at day 7 when compared to the control. This is 
likely the result of both decreased type II collagen expression and increased type I collagen 
expression. By day 28, however, type II/type I collagen fold ratios were similar for all 
groups with the exception of the group incorporating 225 kDa PLL at 500 ng per construct.
In addition to size dependent effects of PLL on the type II collagen gene expression and type 
II/type I collagen fold ratio, dosage dependent effects were observed particularly in 
formulations containing PLL of higher MW (225 kDa). Specifically, the incorporation of 
PLL at 500 ng per construct resulted in the highest aggrecan expression as compared to the 
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250 ng per construct and the control groups (Figure 4c). Lastly, the mineralization of these 
cell-laden hydrogels as influenced by the incorporation of PLL was also investigated. The 
amounts of calcium were normalized to day 0 values within each group in order to reflect 
the mineralization capacity of hydrogels from each of the formulations tested, and hence, do 
not necessarily depict total calcium amounts. The incorporation of PLL, regardless of size or 
loading amount, inhibited increases in mineralization over time (Figure 4d). Indeed, only 
hydrogels from the control group showed increased normalized calcium when compared to 
all other PLL-laden hydrogels at both days 7 and 28.
3.4 Effects of PLL Presentation in Combination With OPF MW on the Chondrogenic Gene 
Expression and Condensation Signaling of Encapsulated MSCs
From the study above, we determined that the incorporation of 225 kDa PLL within cell-
laden OPF hydrogels at a loading concentration of 500 ng per construct produced the 
greatest effect on chondrogenic gene expression without enhancing mineralizing potential. 
Based on our previous observation that hydrogels fabricated from OPF of higher MW can 
enhance the chondrogenic gene expression of encapsulated cells [35], we sought to evaluate 
the effect of PLL incorporation (using the optimized parameters above) in combination with 
varying OPF MW (10 or 35K) on the cellularity, synthetic activity, and chondrogenic gene 
expression of encapsulated MSCs (Table 5). These hydrogels were cultured in serum-free 
and defined chondrogenic medium without β-GP nor external growth factors over 28 days in 
vitro in order to isolate the effects of PLL presentation on MSC chondrogenic gene 
expression in synthetic hydrogels.
As shown in Figure 5a, using DNA content as an indicator of cellularity, a decrease in DNA 
content after day 0 was initially observed for all groups, which is typically expected from 
the encapsulation of cells in synthetic hydrogel systems [42, 43]. DNA levels were then 
stabilized within each group for most formulations following day 7 with the exception of 
35K PLL-laden hydrogels, which experienced a slight increase in cellularity following day 
14. By day 28, 10K PLL-laden hydrogels maintained the lowest DNA content when 
compared to all other groups.
In evaluating GAG synthetic activity, we found that the incorporation of PLL led to 
increased GAG deposition in cell-laden 10K OPF but not 35K OPF hydrogel composites at 
day 14. Indeed, 10K OPF hydrogels loaded with PLL were the only experimental group that 
displayed increases in GAG synthetic activity from encapsulation until day 14, after which 
their normalized GAG values decreased (Figure 5b). For the analysis of the collagen 
synthetic activity, HYP/DNA values were normalized to the day 0 values within each group 
in order to elucidate increases in collagen synthetic activity over time as well as factor out 
the collagen content associated with the encapsulated GMPs. Similarly for collagen 
synthetic activity, differences between groups were again only observed at day 14, where 
both the 10K and 35K OPF groups containing PLL displayed increased collagen deposition 
when compared to their respective non-PLL loaded counterparts (Figure 5c). Furthermore, 
PLL-laden hydrogels fabricated with 10K OPF macromers exhibited enhanced activity when 
compared to those fabricated with 35K OPF macromers. Such an effect was not observed 
between the two non-PLL containing groups. Histological sections for GAG and collagen 
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showed slight increases in staining for the 10K or both the 10K and 35K PLL-laden groups, 
respectively (Figure 6).
In addition to the biochemical analyses, the type II collagen and aggrecan gene expression, 
and the type II/type I collagen expression ratio were evaluated as indicators of chondrogenic 
differentiation. Within defined culture conditions, changes in OPF MW (as opposed to PLL 
loading) appeared to dominate trends in type II collagen gene expression. PLL-laden 35K 
OPF hydrogels displayed enhanced type II collagen expression when compared to their 
corresponding 10K OPF counterparts at both early and late time points (Figure 7a). Some 
transient changes in type II collagen expression were observed at day 14 as a result of both 
increasing OPF MW and PLL incorporation. For aggrecan, while the inclusion of PLL into 
10K OPF hydrogels enhanced expression levels at day 7, this was not observed for the 35K 
hydrogels (Figure 7b). Notably, aggrecan expression levels were similarly increased for both 
35K OPF groups when compared to the 10K OPF controls. Similar to the trends observed 
for type II collagen, the aggrecan gene expression fluctuated after day 7 with the 10K OPF 
control group expressing the highest levels of aggrecan at day 14. By day 28, all groups 
exhibited comparable aggrecan gene expression, highlighting an early effect of PLL on 
chondrogenic gene expression. Lastly, the type II/type I collagen fold ratio was also 
evaluated as an indicator of hyaline-like or fibrocartilage-like differentiation. While there 
appeared to be no additive or synergistic effects between the factors of PLL incorporation or 
OPF MW on MSC chondrogenic gene expression within culture conditions free of external 
stimuli including growth factors and β-GP, the inclusion of PLL stimulated increases in type 
II/type I fold ratios at day 7 for 35K OPF hydrogels and at day 28 for 10K OPF hydrogels 
(Figure 7c).
In addition to the standard chondrogenic markers described above, we also analyzed the 
gene expression levels of Sox9, VSN, type X collagen, and CDH2. Although there were no 
differences in gene expression levels observed between groups for both Sox9 and VSN at 
early or late time points, the addition of PLL into OPF hydrogels appeared to affect some 
changes at day 14 (Figures 8a and 8b). Interestingly, the inclusion of PLL within 10K OPF 
hydrogels actually resulted in a decrease in both Sox9 and VSN gene expression at 
intermediate times. However, differences in Sox9 and VSN expression were no longer 
present by day 28. For type X collagen gene expression, the expression levels for all groups 
were generally below the detection threshold from day 7 forward. To evaluate any possible 
effects of PLL on the condensation signaling of encapsulated MSCs, CDH2 gene expression 
was also assessed. Similar to type II collagen expression, changes in CDH2 expression were 
primarily influenced by the factor of OPF MW. MSCs encapsulated in 35K OPF hydrogel 
composites without PLL displayed lower CDH2 expression after day 7 when compared to 
both 10K OPF formulations (Figure 8c). While initially lower when compared to the 10K 
OPF groups at day 7, the CDH2 expression levels of PLL-laden 35K OPF hydrogels 
increased over time and exhibited similar values by day 28. Importantly, the incorporation of 
PLL effected an increase in CDH2, and hence N-cadherin, expression, which was observed 
between the 35K OPF groups at day 28 (Figure 8c).
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4. Discussion
To address the limited regenerative potential of current cartilage engineering strategies, it is 
theorized that the induction of developmental processes can instruct host or transplanted 
cells to adopt native morphogenetic programs for robust tissue regeneration [50, 51]. During 
condensation, increased cell-cell interactions mediated by cell-cell adhesion molecules (such 
as N-cadherin) [52, 53] permit the exchange of chondrogenic signals between cells [27, 54–
56]. Indeed, it has been previously shown that the functionalization of hydrogels with N-
cadherin mimetic peptides was sufficient to stimulate the chondrogenic differentiation of 
encapsulated MSCs [57]. In a different approach, early studies have demonstrated that the 
treatment of chick mesenchymal micromasses with soluble PLL elicited a size- and dose- 
dependent response on cartilage nodule formation [30] and have shown that PLL promotes 
chondrogenesis via the upregulation of functional N-cadherin expression [31]. Whether PLL 
can exert chondro-stimulatory effects in a three-dimensional context, however, still remains 
to be investigated. By successfully leveraging these properties of PLL, especially given its 
ubiquity in biomedical technologies, one can potentially provide a clinically relevant way of 
implementing an effective developmental approach for cartilage tissue regeneration.
In the present study, we hypothesized that the incorporation of PLL polypeptides into 
synthetic OPF hydrogel systems, in addition to influencing hydrogel swelling and 
degradation properties, will stimulate the chondrogenic gene expression of encapsulated 
MSCs. We found that PLL remained largely retained within OPF hydrogels when 
incorporated during hydrogel fabrication despite differences in the initial loading 
concentration. The retention of PLL is likely due to the formation of a tight interpenetrating 
network held together via electrostatic interactions between the cationic polypeptide and 
electronegative groups with partial negative charges (i.e. carbonyl groups) on the OPF 
polymer backbone. Incorporation and retention of cationic PLL within hydrogels also 
resulted in ionization of the resultant constructs, which affected their swelling behavior and 
degradation. Characterization of hydrogel swelling at early time points generally showed 
that PLL-laden constructs initially exhibited greater swelling ratios when compared to blank 
controls. Typically, swelling of a neutral biopolymer hydrogel network is largely governed 
by the thermodynamic compatibility of the solute (i.e. the polymer chains) with the aqueous 
solvent and the rubber elasticity of the polymer chains as described by the Flory-Rehner 
theory [58]. When the polymer chains are ionized, however, the presence of polymer-
polymer charge interactions can also significantly influence hydrogel swelling behavior, 
where like charges support swelling while opposite charges hinder swelling [59–61]. The 
incorporation of cationic PLL polypeptides into OPF hydrogels introduced a surplus of 
positively charged moieties that led to an initial repulsion of similarly charged polymer 
chains in the interpenetrating network. Over time, hydrolytic degradation of the OPF 
polymer chains yielded negatively charged moieties in the form of carboxylic acids and 
oligomerized fumaric acids [32, 62] that possess an electrostatic affinity for cationic groups. 
Subsequent affinity between the interpenetrating PLL and OPF chains opposes hydrogel 
swelling, which was observed at later time points in the swelling study where PLL-laden 
groups generally swelled less in comparison to controls.
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Regarding hydrogel degradation, it was anticipated that the electrostatic interactions 
between the sol fraction and incorporated PLL would lead to a reduction in initial mass loss. 
While the differentiating trends in mass loss amongst the varying hydrogel formulations 
were generally minor, blank OPF hydrogels of both 10K and 35K OPF MW both did display 
greater mass loss than some PLL-laden groups at early time points up until day 7. Such 
changes in hydrogel swelling behavior and degradation suggest that PLL can be leveraged 
for the generation of hydrogel constructs with desirable dynamic swelling properties for 
cartilage engineering applications.
We also evaluated the chondrogenic gene expression of encapsulated MSCs as effected by 
PLL size and loading dosage. From our results, we showed that PLL primarily stimulated 
the expression of chondrogenic gene markers at early time points, where dose-dependent 
effects were mainly discerned for aggrecan expression and size-dependent effects were 
mainly detected for type II collagen expression. The induction of hyaline-like MSC 
chondrogenic gene expression profiles as a result of PLL presentation was most evident in 
the type II/type I collagen expression ratio. The PLL225–500 group induced the highest 
chondrogenic type II/type I collagen gene expression ratios of MSCs encapsulated within 
OPF hydrogels when compared to all other groups. As this was due in large part to a 
decrease in type I collagen gene expression for the PLL225–500 group, these results suggest 
that PLL may inhibit chondrogenic dedifferentiation of MSCs in such hydrogel systems. 
Previously, it was only shown that PLL promoted increases in chondrogenic gene expression 
of MSCs in monolayer [34]. Here, we show that PLL can also induce the chondrogenic gene 
expression of MSCs encapsulated within hydrogels. However, the chondrogenic 
differentiation of MSCs in vitro typically does not arrest at the chondrocyte stage and often 
leads to hypertrophy followed by subsequent formation of calcified tissues that are 
detrimental to the function of articular cartilage [63]. Interestingly, all PLL-laden groups 
exhibited decreased calcium accumulation over time when compared to the negative control. 
This could possibly be attributed to the cationic forces of the incorporated PLL inhibiting 
the nucleation of positively charged calcium within these cell-laden constructs via 
electrostatic repulsion.
To further investigate the chondro-stimulatory properties of PLL within the context of a 
well-established hydrogel system, we hypothesized (in our second cell encapsulation study) 
that the effects of PLL would work synergistically with increases in OPF MW toward 
enhancing the chondrogenic synthetic activity and gene expression of encapsulated MSCs. 
However, we did not observe any combinatory effects of PLL and OPF MW on 
chondrogenic gene expression under the conditions investigated. For the biochemical 
characterization, overall construct cellularity decreased after encapsulation and stabilized for 
the duration of culture as expected [19, 36, 42, 43]. PLL incorporation significantly 
heightened both the GAG and collagen synthetic activity, especially at intermediate time 
points. However, the buildup of detectable extracellular matrix diminished following day 14, 
likely as a result of overall construct degradation. Although the exact mechanism of PLL’s 
stimulatory effects on chondrogenesis still remains to be determined, it was established that 
PLL promoted the pericellular retention of proteoglycans as well as other anionic 
extracellular matrix components, allowing for cumulative extracellular matrix assembly and 
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subsequent cartilage nodule formation [64]. Given that a synthetic hydrogel system was 
employed for our studies to isolate the effects of PLL, we did not expect to observe 
significant extracellular matrix deposition over time since other more potent growth factors 
were not incorporated. This outcome was indicated in the histology, which also suggests 
PLL’s early effects on chondrogenic gene expression. While not investigated here, data from 
the present study would be enhanced with additional analyses characterizing the production 
of extracellular matrix components specific to articular cartilage, such as type II collagen.
In elucidating the effect of OPF MW and PLL incorporation on chondrogenic gene 
expression, we found that increases OPF MW generally enhanced gene expression, which 
corroborates previous results from our laboratory [35]. While both PLL-laden and PLL-free 
35K OPF composites also exhibited heightened aggrecan expression when compared to 10K 
OPF controls early on, we found that the incorporation of PLL to 10K OPF hydrogels also 
enhanced their early aggrecan expression. Further analysis of the type II/type I collagen 
expression ratio confirmed that incorporation of PLL into OPF hydrogel composites indeed 
enhanced the hyaline-like chondrogenic gene expression of encapsulated MSCs. Although 
no direct assessments were made in the present study, comparison of the gene expression 
data from the two cell encapsulation experiments suggests that β-GP played a role in 
facilitating the stimulatory effects of PLL on chondrogenic gene expression. Since β-GP is 
known to stimulate the osteogenic differentiation of MSCs via increasing alkaline 
phosphatase activity and altering local phosphate ion concentrations [65, 66], there may 
exist some interplay between β-GP and PLL that influences both bone and cartilage 
development, since both processes are preceded by condensation in embryo [25]. This 
particular phenomenon, although not researched in the current study, warrants further 
investigation.
As a proteoglycan that shares common features with aggrecan, versican is thought to play a 
prevalent role in the regulation of extracellular matrix assembly during pre-cartilaginous 
condensation [67, 68]. Additionally, sox9 is understood to be essential for cartilage 
formation [69] and is often considered an early chondrogenic marker. Cells encapsulated 
within these hydrogels did not undergo hypertrophy as indicated by the inability to detect 
(below detection threshold) any type X collagen gene expression. Furthermore, the absence 
of any discernable trends in versican and sox9 gene expression as a result of PLL 
incorporation highly suggests that PLL may have likely stimulated chondrogenesis via an 
indirect mechanism through N-cadherin. Notably, we detected an increase in N-cadherin 
expression for 35K OPF hydrogel composites at day 28 as a result of PLL incorporation 
when compared to the PLL-free 35K control, which corroborates previously reported data; 
Woodward and Tuan found that PLL stimulates the chondrogenic differentiation of 
mesenchymal micromass cultures by upregulating functional N-cadherin expression, both of 
which are essential for promoting pre-cartilaginous condensation [31]. However, differences 
in temporal N-cadherin expression patterns when compared to 2D cultures indicate that the 
incorporation parameters of PLL in 3D hydrogels, such as size and dosage, may require 
further optimization in order to accurately recapitulate proper conditions for condensation. 
While PLL does not exist naturally in vivo [27], its ability to interact with cells 
intracellularly as well as though their extracellular matrix [31] suggest the existence of 
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biological counterparts to PLL. PLL has indeed been thought to mimic the chondrogenesis-
promoting actions of procollagen and fibronectin, both of which contain cationic regions 
similar to PLL [27, 64, 70–72]. Whether or not PLL adopts similar mechanisms in 
promoting chondrogenic differentiation in 3D hydrogel systems requires further study. 
Additionally, the chondrostimulatory effects of PLL should also be confirmed in vivo using 
an orthotopic animal model in future investigations. Interestingly, decreasing OPF MW also 
appeared to increase N-cadherin expression in MSCs encapsulated in OPF hydrogel 
systems. This phenomenon could be attributed to increases in hydrogel osmotic pressure due 
to decreases in MW between crosslinked chains as described by the Flory-Rehner theory [5, 
58, 73–75], which would likely simulate the physical cues present as a result of dense cell-
cell interactions during pre-cartilaginous condensation [76, 77].
5. Conclusion
In summary, we developed a 3D hydrogel platform incorporating PLL as an inductive factor 
for stimulating the chondrogenesis of encapsulated MSCs. Upon loading into synthetic 
hydrogels, PLL remains largely retained where it is capable of exerting size- and dose- 
dependent changes on the swelling behavior and degradation of the resultant composite 
constructs. We demonstrate that the incorporation of PLL into synthetic OPF hydrogels 
dynamically influences their swelling behavior, which may be leveraged for the 
development of constructs with desirable dynamic swelling properties for cartilage tissue 
engineering applications. Within these hydrogel composites, PLL also stimulated early gene 
expression of MSCs, in which higher MW and loading amounts resulted in greater 
chondrogenic gene expression. Additionally, the incorporation of PLL also promoted an 
increase in N-cadherin expression under certain conditions. Together, our results 
demonstrate that PLL can function as an inductive factor that primes the cellular 
microenvironment for early chondrogenic gene expression but may require additional 
stimulatory factors for the generation of fully functional chondrocytes. By leveraging these 
chondro-stimulatory properties of PLL, notably given its ubiquity in biomedical 
technologies, we provide herein a clinically relevant and developmental-inspired strategy for 
cartilage tissue regeneration.
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Figure 1. 
An indirect measure of PLL retention through the detection of released PLL is shown in (A) 
PBS (pH 7.4) or in (B) basic buffer (pH 13) after 24 h between OPF controls, OPF 
hydrogels loaded with PLL during fabrication (pre), and OPF hydrogels loaded with PLL 
after fabrication (post). Within each incubation condition, groups not connected by the same 
letters are significantly different (p < 0.05). Within each group, * indicates a difference 
between incubation conditions. Released PLL is shown in (C) PBS and in (D) basic buffer 
over 21 days between OPF-PLL and blank controls. At each time point for (C) and (D), the 
* indicates a significant difference between groups (p<0.05). Error bars represent the 
standard deviation (n=3).
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Figure 2. 
Cumulative PLL-FITC release from (A) 10K OPF hydrogels and (B) 35K OPF hydrogels 
loaded with PLL at 500 ng/hydrogel, 5 µg/hydrogel, or 20 µg/hydrogel over 28 days is 
shown. Visualization of uniformly distributed PLL-FITC loaded into hydrogel constructs at 
each concentration, which is shown at days 7 and 28 after incorporation for (C) 10K 
hydrogels and (D) 35K hydrogels. Scale bar = 200 µm.
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Figure 3. 
Swelling ratio profiles are shown for (A) 10K OPF or (B) 35K OPF hydrogel formulations 
over 28 days. The mass loss profiles are shown for (C) 10K OPF or (D) 35K OPF hydrogel 
formulations over 28 days. The * indicates a difference between the 10K OPF or 35K OPF 
blank control group and at least one of the corresponding PLL-laden groups at that time 
point. Error bars represent the standard deviation (n=4).
Lam et al. Page 24
Biomaterials. Author manuscript; available in PMC 2017 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 4. 
Quantitative gene expression is shown for (A) type II collagen expression, (B) type II/type I 
collagen expression ratio, and the (C) aggrecan expression at days 7 and 28 for the first cell 
encapsulation study. The type II/type I collagen expression ratio is shown using a 
logarithmic scale for the y-axis. (D) The normalized calcium content at various time points. 
At each individual time point, groups not connected by the same letter are significantly 
different (p<0.05). Comparing time points within each individual group, time points 
connected by a bar are significantly different (p<0.05). The * indicates a significant 
difference when compared to the day 0 value of that corresponding group (p<0.05). Error 
bars represent the standard deviation (n=4).
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Figure 5. 
(A) DNA content, (B) GAG synthetic activity, and (C) HYP synthetic activity of cell-laden 
composite hydrogels are shown at various time points. At each individual time point, groups 
not connected by the same letter are significantly different (p<0.05). Within each group at 
each individual time point, time points not connected by the same symbol are significantly 
different (p<0.05). Error bars represent the standard deviation (n=4).
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Figure 6. 
Histological evaluation of GAG production using (A) Alcian Blue, where increasing shades 
of blue indicate greater sulfated GAG deposition, and collagen production using (B) 
Picrosirius Red, where increasing shades of red/orange indicate greater collagen deposition, 
are shown at day 14. GMPs and encapsulated MSCs are indicated with black arrows and 
orange arrowheads, respectively. Scale bar represents 200 µm for all images.
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Figure 7. 
Quantitative gene expression is shown for (A) type II collagen, (B) aggrecan, and the (C) 
type II/type I collagen expression ratio at various time points for the second cell 
encapsulation study. At each individual time point, groups not connected by the same letter 
are significantly different (p<0.05). Comparing time points within each individual group, 
time points connected by a bar are significantly different (p<0.05). Error bars represent the 
standard deviation (n=4).
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Figure 8. 
Quantitative gene expression is shown for (A) Versican, (B) Sox9, and (C) CDH2 at various 
time points for the second cell encapsulation study. At each individual time point, groups 
not connected by the same letter are significantly different (p<0.05). Comparing time points 
within each individual group, time points connected by a bar are significantly different 
(p<0.05). Error bars represent the standard deviation (n=4).
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Table 1
Experimental Design for the Determination of PLL Retention
i. Group (n=3) Incubation
Condition
PLL Loading
Method
PLL Dosage
(µg/hydrogel)
OPF pH 7.4, 13 -- --
OPF-Pre pH 7.4, 13 During Fabrication 20
OPF-Post pH 7.4, 13 After Fabrication 20
ii. Group (n=3) Incubation
Condition
PLL Loading
Method
PLL Dosage
(µg/hydrogel)
OPF pH 7.4 -- --
OPF-Pre pH 7.4 During Fabrication 20
i.) Samples were incubated at both pH conditions in parallel, and supernatants were collected and analyzed at 2 and 24 h post-fabrication. ii.) 
Supernatants were collected at 2 h, 1, 7, 14, and 21 days for analysis. Samples were then transferred to pH 13 incubation conditions for 24 h before 
collection and analysis.
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Table 2
Experimental Design for the Determination of PLL-FITC Release
Group (n=3) OPF MW
(g/mol)
PLL MW
(kDa)
PLL Dosage
(per hydrogel)
OPF 10K, 35K 50 --
OPF-500ng 10K, 35K 50 500 ng
OPF-5µg 10K, 35K 50 5 µg
OPF-20µg 10K, 35K 50 20 µg
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Table 3
Full Factorial Study to Characterize Swelling Behavior and Degradation of PLL-Laden Hydrogels
Levels (n=4) (A) PLL MW
(kDa)
(B) PLL Dosage
(per hydrogel)
(C) OPF MW
(g/mol)
Hi 225 20 µg 35K
Lo 50 500 ng 10K
PLL-free 10K and 35K OPF hydrogels were utilized as negative controls.
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Table 4
Cell Encapsulation Study to Characterize the Effects of PLL Size and Dosage on Chondrogenic Gene 
Expression
Group (n=4) PLL MW (kDa) PLL Dosage
(ng per hydrogel)
OPF -- --
PLL50–250 50 250
PLL225–250 225 250
PLL50–500 50 500
PLL225–500 225 500
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Table 5
Cell Encapsulation Study to Characterize the Effects of OPF Size and PLL Presentation on Chondrogenic 
Gene Expression and Condensation
Group (n=4) PLL MW and Dosage OPF MW (g/mol)
10K OPF -- 10K
35K OPF -- 35K
10K 500ng 225 kDa; 500 ng/hydrogel 10K
35K 500ng 225 kDa; 500 ng/hydrogel 35K
Biomaterials. Author manuscript; available in PMC 2017 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Lam et al. Page 35
Table 6
Primer Sequences Used for Quantitative RT-PCR
Gene Primer Sequence
Type II Collagen
5'-CTGCAGCACGGTATAGGTGA-3'
5'-AACACTGCCAACGTCC AGAT-3'
Type I Collagen
5'-AGCAGACGCATGAAGGCAAG-3'
5'-CCCAGAATGGAGCAGTGGTTA-3'
Aggrecan
5'-CGTAAAAGACCTCACCCTCCA-3'
5'-GCTACGGAGACAAGGATGAGT-3'
Versican (VSN)
5'-GCTACACCCTTCCCATCAGT-3'
5'-GAATTTGCTCTGAGGAAGCC-3'
Sox9
5'-GAGCGAAGAGGACAAGTTCC-3'
5'-GTCCAGTCGTAGCCCTTGAG-3'
Type X Collagen
5'-ATGGAGTGTTCTACGCTGAG-3'
5'-CCTCTCACTGGTATACCTTTACT-3'
N-Cadherin (CDH2)
5'-CTGCTATTGATGCGGATGAC-3'
5'-TGAACATGTTGGGAGAAGGA-3'
GAPDH
5'-TCACCATC TTCCAGGAGCGA-3'
5' -CACAATGCCGAAGTGGTCGT-3'
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